Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...

Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...

As we begin 2025, I wanted to take the opportunity to recap on the progress we made in 2024 and key upcoming catalysts including our planned entrance into the multi-billion dollar U.S. market. 2024 ...

"The idea that they can somehow obliterate these sources is dead wrong — scientists in general and astronomers in particular ...

And what the heck is bio-convergence, anyway? It's where biology, engineering and artificial intelligence converge.

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

The landscape of modern dating has changed drastically in the last decade. Apps once used for casual hookups are now sending more and more people down the aisle. According to eharmony, 20% of current ...

Johnson & Johnson executive praises China's biotech innovation in oncology and immunology, highlighting potential future ...

According to leading experts, the following topics must now feature at the very top of the political agenda: the transition ...

Windfall Bio, a leader in methane-to-value solutions, announced today that its “OptiMem” product has received OMRI (Organic Materials Review Institute) status for use in certified organic operations ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...